Cargando…
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study
BACKGROUND: We have reported that serum progranulin (PGRN) levels are clinically significant in predicting recurrence in patients with HR-positive breast cancer. The aim of the present study was to examine whether PGRN levels might be associated with breast cancer mortality. METHODS: This was a coho...
Autores principales: | Koo, Dong-Hoe, Lee, Keun Seok, Sim, Sung Hoon, Chae, Heejung, Lee, Eun-Gyeong, Han, Jai Hong, Jung, So-Youn, Lee, Seeyoun, Kang, Han-Sung, Lee, Eun Sook, Park, Cheol-Young, Oh, Sang Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112348/ https://www.ncbi.nlm.nih.gov/pubmed/37081941 http://dx.doi.org/10.2147/BCTT.S406685 |
Ejemplares similares
-
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy
por: Lee, Eun-Gyeong, et al.
Publicado: (2023) -
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer
por: Song, Ran, et al.
Publicado: (2023) -
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021) -
Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort
por: Jo, Heein, et al.
Publicado: (2020) -
Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging study
por: Kim, Yunju, et al.
Publicado: (2021)